Safety and efficacy of biphasic insulin aspart 30 in type 2 diabetes patients switched from either biphasic or basal human insulin: results from the Gulf cohort of the A1chieve study

Safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes patients switched from biphasic human insulin 30: Results from the Filipino cohort of the A1chieve study

Diabetes Research and Clinical Practice ◽

10.1016/s0168-8227(13)70008-1 ◽

2013 ◽

Vol 100 ◽

pp. S35-S40 ◽

Cited By ~ 3

Author(s):

Mary Anne Lim-Abrahan ◽

Susan Yu-Gan ◽

Anand B. Jain ◽

Leorino M. Sobrepena ◽

Veronica A. Racho

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Transferring type 2 diabetes patients with uncontrolled glycaemia from biphasic human insulin to biphasic insulin aspart 30: experiences from the PRESENT study

Current Medical Research and Opinion ◽

10.1185/030079907x253636 ◽

2007 ◽

Vol 23 (12) ◽

pp. 3209-3214 ◽

Cited By ~ 29

Author(s):

M. Shestakova ◽

S. K. Sharma ◽

M. Almustafa ◽

K. W. Min ◽

N. Ayad ◽

...

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Clinical safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes patients switched from biphasic human insulin 30: Results from the Indonesian cohort of the A1chieve study

Diabetes Research and Clinical Practice ◽

10.1016/s0168-8227(13)70009-3 ◽

2013 ◽

Vol 100 ◽

pp. S41-S46 ◽

Cited By ~ 4

Author(s):

Pradana Soewondo ◽

Dharma Lindarto ◽

Sony Wibisono ◽

Olly Renaldi ◽

Tjokorda Gde Dalem-Pemayun

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Clinical Safety ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

PDB24 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING

Value in Health ◽

10.1016/s1098-3015(10)75002-6 ◽

2009 ◽

Vol 12 (7) ◽

pp. A405-A406

Author(s):

E Suchankova ◽

T Doležal ◽

Z Pisarikova ◽

K Rychna ◽

D Bartaskova

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

Cost Effectiveness Analysis ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Effectiveness Analysis ◽

PDB5 GLYCAEMIC CONTROL AND INSULIN UTILIZATION IN UK PATIENTS WITH TYPE 2 DIABETES INITIATED ON EITHER BIPHASIC INSULIN ASPART 30 OR BIPHASIC HUMAN INSULIN 30

Value in Health ◽

10.1016/s1098-3015(10)72252-x ◽

2010 ◽

Vol 13 (3) ◽

pp. A55 ◽

Cited By ~ 1

Author(s):

W Fakhoury ◽

H Richter ◽

T Christensen ◽

TL Thomsen ◽

D Irwin ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

A double-blind, randomised, crossover study to investigate the difference in frequency of episodes of hypoglycaemia during treatment with Biphasic Insulin Aspart 30 (NovoMix®30) compared to Biphasic Human Insulin 30 (Mixtard® 30) in patients with well-controlled, type 2 diabetes

http://isrctn.org/> ◽

10.1186/isrctn34091554 ◽

2013 ◽

Author(s):

Paul McNally

Keyword(s):

Type 2 Diabetes ◽

Crossover Study ◽

Human Insulin ◽

Insulin Aspart ◽

Double Blind ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

The Difference

Clinical experience of switching from biphasic human insulin to biphasic insulin aspart 30 in Indian patients with type 2 diabetes in the A1chieve study

Indian Journal of Endocrinology and Metabolism ◽

10.4103/2230-8210.131759 ◽

2015 ◽

Vol 19 (1) ◽

pp. 110 ◽

Cited By ~ 2

Author(s):

Shahid Akhtar ◽

Raman Shetty ◽

Ajay Kumar ◽

AK Das ◽

Sanjay Kalra

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Clinical Experience ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Indian Patients ◽

Cost-Effectiveness of Switching to Biphasic Insulin Aspart 30 from Human Insulin in Patients with Poorly Controlled Type 2 Diabetes in South Korea

Value in Health ◽

10.1111/j.1524-4733.2009.00628.x ◽

2009 ◽

Vol 12 ◽

pp. S55-S61 ◽

Cited By ~ 6

Author(s):

Kyoung Hee Lee ◽

Se Jin Seo ◽

Jayne Smith-Palmer ◽

James L. Palmer ◽

Jeremy White ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

South Korea ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral anti

Diabetes Obesity and Metabolism ◽

10.1111/dom.13454 ◽

2018 ◽

Vol 20 (12) ◽

pp. 2740-2747

Author(s):

Lixin Guo ◽

Li Chen ◽

Baocheng Chang ◽

Liyong Yang ◽

Yu Liu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Controlled Study ◽

Efficacy And Safety ◽

Open Label ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

DB1 PROJECTED COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 IN TYPE 2 DIABETES PATIENTS SWITCHED FROM BIPHASIC HUMAN INSULIN IN THE UNITED STATES

Value in Health ◽

10.1016/s1098-3015(10)73111-9 ◽

2009 ◽

Vol 12 (3) ◽

pp. A10 ◽

Cited By ~ 1

Author(s):

M Aagren ◽

TL Thomsen ◽

VK Knudsen

Keyword(s):

United States ◽

Type 2 Diabetes ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

The United States ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽